Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis

Launched by UNIVERSITY HOSPITAL, GENEVA · Oct 30, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether lavender essential oil chest wraps can help relieve cough and improve breathing in infants with bronchiolitis, a common respiratory condition. The researchers want to see if these wraps can also help reduce nighttime awakenings and make things easier for parents. Infants participating in the study will either receive the standard care they usually get for bronchiolitis, along with the lavender wraps, or just the standard care alone. The trial is taking place at two hospitals in Switzerland.

To be eligible for this trial, infants must have a clinical diagnosis of bronchiolitis and need to be hospitalized. There are certain conditions that would exclude infants from participating, such as serious heart or lung problems, or if they have had more than three episodes of bronchiolitis. Parents who decide to enroll their child can expect to help with the study by providing consent for their child to participate, and they’ll be informed about the care their child will receive throughout the trial. This study aims to find out if lavender oil wraps can offer any additional benefits for infants suffering from this condition.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Bronchiolitis: clinical diagnosis based on the combination of respiratory distress (tachypnea, grunting, nasal flaring, retractions, and/or need for supplementary oxygen) and fine crackles sometimes accompanied by wheezing on auscultation.
• • Hospitalization.
• • Written informed consent.
• Exclusion criteria:
• • Patients with underlying diseases that impact respiratory or heart function (congenital heart disease, congenital malformation of the lung or airway system and severe chronic lung disease).
• • More than 3 episodes of bronchiolitis.
• • Critically ill infants who have an immediate need for intensive care unit (ICU) admission.
• • Respiratory deterioration needing Continuous positive airway pressure (CPAP) or transfer to ICU during study enrollment.
• • Atopic dermatitis, eczema or other skin lesions (particularly on the chest).
• • Oncologic disease.
• • Premature infants with mild bronchopulmonary dysplasia will not be excluded.